Tectonic Therapeutic, Inc.
TECX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001681087
In the last 90 days, Tectonic Therapeutic, Inc. insiders filed 0 open-market purchases and 2 sales; 122 institutions reported holding it in 13F filings for Q2 2026, worth $479.9M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Tectonic Therapeutic, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −7 vs. Q1 2024
- Shares held
- 5.35M
- +2.88M (+117.1%) vs. Q1 2024Converted for a 1-for-12 split
- Total value
- $88.1M
- +$52.8M (+149.8%) vs. Q1 2024
- New holders
- 4
- 10 more added
- Sold out
- 11
- 14 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TECX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $479.9M |
| Q1 2026 | 111 | $426.8M |
| Q4 2025 | 105 | $288.1M |
| Q3 2025 | 99 | $189.9M |
| Q2 2025 | 82 | $240.7M |
| Q1 2025 | 78 | $198.8M |
| Q4 2024 | 70 | $354.9M |
| Q3 2024 | 53 | $217.4M |
| Q2 2024 | 40 | $88.1M |
| Q1 2024 | 47 | $35.2M |
| Q4 2023 | 45 | $32.2M |
| Q3 2023 | 48 | $39.9M |
| Q2 2023 | 41 | $18.9M |
| Q1 2023 | 48 | $22.8M |
| Q4 2022 | 45 | $14.8M |
| Q3 2022 | 54 | $15.7M |
| Q2 2022 | 64 | $23.8M |
| Q1 2022 | 81 | $38.8M |
| Q4 2021 | 94 | $134.9M |
| Q3 2021 | 101 | $166.5M |
| Q2 2021 | 97 | $287.7M |
| Q1 2021 | 99 | $423.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Tectonic Therapeutic, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Group One Trading, L.P. | 1 | $16 | 0.00% | −0−7.7% | ReducedConverted for a 1-for-12 split |
| JPMorgan Chase & Co | 22 | $362 | 0.00% | −1−6.4% | ReducedConverted for a 1-for-12 split |
| National Bank of Canada | 31 | $491 | 0.00% | −1−2.1% | ReducedConverted for a 1-for-12 split |
| Rhumbline Advisers | 100 | $1.65K | 0.00% | −1−0.7% | ReducedConverted for a 1-for-12 split |
| Tower Research Capital LLC (TRC) | 112 | $1.84K | 0.00% | −148−56.9% | ReducedConverted for a 1-for-12 split |
| Royal Bank of Canada | 157 | $3.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Bank of America Corp | 236 | $3.89K | 0.00% | +236+141,500.0% | AddedConverted for a 1-for-12 split |
| BNP Paribas Arbitrage, SA | 249 | $4.10K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| CWM, LLC | 531 | $9.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Barclays PLC | 1,441 | $23.7K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| FNY Investment Advisers, LLC | 3,376 | $55.0K | 0.04% | −2,874−46.0% | ReducedConverted for a 1-for-12 split |
| Clearstead Advisors, LLC | 8,140 | $134.1K | 0.00% | +8,140 | New |
| Wells Fargo & Company | 9,725 | $160.2K | 0.00% | −754−7.2% | ReducedConverted for a 1-for-12 split |
| State Street Corp | 11,677 | $192.3K | 0.00% | −61−0.5% | ReducedConverted for a 1-for-12 split |
| Two Sigma Advisers, LP | 13,071 | $215.3K | 0.00% | −11,621−47.1% | ReducedConverted for a 1-for-12 split |
| Morgan Stanley | 13,189 | $217.2K | 0.00% | −120−0.9% | ReducedConverted for a 1-for-12 split |
| Two Sigma Investments, LP | 14,545 | $239.6K | 0.00% | −7,993−35.5% | ReducedConverted for a 1-for-12 split |
| Boothbay Fund Management, LLC | 15,885 | $261.6K | 0.01% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Bridgeway Capital Management, LLC | 19,781 | $325.8K | 0.01% | −2,501−11.2% | ReducedConverted for a 1-for-12 split |
| Walleye Capital LLC | 23,984 | $395.0K | 0.00% | +12,680+112.2% | AddedConverted for a 1-for-12 split |
| Geode Capital Management, LLC | 31,033 | $511.3K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Exome Asset Management LLC | 32,389 | $533.4K | 0.47% | +27,294+535.8% | AddedConverted for a 1-for-12 split |
| Aldebaran Capital, LLC | 41,991 | $691.6K | 0.64% | −1,128−2.6% | ReducedConverted for a 1-for-12 split |
| BlackRock Inc. | 51,113 | $841.8K | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Affinity Asset Advisors, LLC | 58,331 | $960.7K | 0.15% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Ikarian Capital, LLC | 62,836 | $1.03M | 0.32% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Prosight Management, LP | 67,461 | $1.11M | 0.33% | +20,251+42.9% | AddedConverted for a 1-for-12 split |
| Tang Capital Management LLC | 79,166 | $1.30M | 0.13% | +8,099+11.4% | AddedConverted for a 1-for-12 split |
| Aisling Capital Management LP | 84,148 | $1.39M | 0.60% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Renaissance Technologies LLC | 89,029 | $1.47M | 0.00% | +15,015+20.3% | AddedConverted for a 1-for-12 split |
| Acadian Asset Management LLC | 109,629 | $1.80M | 0.01% | +6,568+6.4% | AddedConverted for a 1-for-12 split |
| Verition Fund Management LLC | 140,680 | $2.32M | 0.02% | −19,975−12.4% | ReducedConverted for a 1-for-12 split |
| Vanguard Group Inc | 156,768 | $2.58M | 0.00% | 00.0% | UnchangedConverted for a 1-for-12 split |
| ADAR1 Capital Management, LLC | 356,878 | $5.88M | 1.18% | +27,307+8.3% | AddedConverted for a 1-for-12 split |
| Atlas Venture Life Science Advisors, LLC | 378,447 | $6.23M | 0.66% | 00.0% | UnchangedConverted for a 1-for-12 split |
| Farallon Capital Management, L.L.C. | 431,010 | $7.10M | 0.04% | +431,010 | New |
| BML Capital Management, LLC | 466,047 | $7.68M | 5.62% | +132,578+39.8% | AddedConverted for a 1-for-12 split |
| 5AM Venture Management, LLC | 646,524 | $10.6M | 2.38% | +646,524 | New |
| EcoR1 Capital, LLC | 849,143 | $14.0M | 0.43% | +849,143 | New |
| FMR LLC | 1,077,538 | $17.7M | 0.00% | +909,402+540.9% | AddedConverted for a 1-for-12 split |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −93,241−100.0% | Sold outConverted for a 1-for-12 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −36,420−100.0% | Sold outConverted for a 1-for-12 split |
| Vazirani Asset Management LLC | 0 | $0 | 0.00% | −12,500−100.0% | Sold outConverted for a 1-for-12 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −5,620−100.0% | Sold outConverted for a 1-for-12 split |
| BBR Partners, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold outConverted for a 1-for-12 split |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −3,224−100.0% | Sold outConverted for a 1-for-12 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −2,877−100.0% | Sold outConverted for a 1-for-12 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −2,030−100.0% | Sold outConverted for a 1-for-12 split |
| Colonial River Wealth Management, LLC | 0 | $0 | 0.00% | −1,348−100.0% | Sold outConverted for a 1-for-12 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −873−100.0% | Sold outConverted for a 1-for-12 split |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −333−100.0% | Sold outConverted for a 1-for-12 split |